• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Despite Strong Financials, Stocks Remain Stuck in Choppy Trade


The stock market's inability to be inspired by the financial sector's strength makes it uncertain whether stocks will log their fifth straight loss, which would make for the stock market's longest losing streak of 2010.

A positive reaction to the financial reform bill has helped financials trade with strength for the entire session, but the broader market has spent the better part of the day stuck in choppy trade.

Banks and financial services stocks displayed strength for the entire session. Their strength follows the finalization of the financial reform bill, which will prohibit banks from making risky bets with their own money, but allows room for some firms to participate in hedge funds and private-equity funds. The bill is expected to be passed in coming weeks and removes an element of uncertainty for the sector -- but there are still uncertainties about its implications.

Market participants showed a brief negative reaction to the final U.S. gross domestic product reading for the first quarter. GDP grew at a slower-than-expected annual rate of 2.7 percent in the quarter, down from a revised estimate of 3 percent in May (which itself was down from the original estimate of 3.2 percent). Personal consumption growth was also revised downward to reflect a softer-than-expected increase of 3.0 percent.

One positive from the report was an upwardly revised 0.7 percent increase in core personal consumption expenditures. The GDP report had little lasting effect on the mood of the market, but stocks did see some buying interest surface after the final June Consumer Sentiment Survey from the University of Michigan came in at a slightly improved 76.0, which is not only above the 75.5 that many had anticipated, but is also the best reading since January 2008.

In earnings news, Oracle Corp. (NASDAQ: ORCL) posted an upside surprise for the latest quarter and issued solid guidance. However, Research in Motion Ltd. (NASDAQ: RIMM) issued a relatively mixed outlook that overshadowed an upside surprise of its own. The contrast in the reports has left the technology sector, which is the largest by market weight, mired with moderate weakness.

The broader market's inability, or unwillingness to be inspired by the financial sector's 1.5% gain has made for mixed action overall this session. In turn, the stock market continues to chop along. The directionless trade makes it uncertain whether stocks will log their fifth straight loss, which would make for the stock market's longest losing streak of 2010.

While action in the broader market remains lackluster, the Russell 2000 Small Cap Index is up a sharp 1.1%. Its strength comes ahead of the annual reconstitution of the Russell averages after the close.

This material presented here has been obtained or derived from sources believed to be accurate, but we do not guarantee its accuracy and it may possibly be incomplete and condensed. The opinions expressed are based upon our study and interpretation of available data. This is not a prospectus; no effort on our part with respect to sale or purchase of any securities is intended or implied. Any stock noted herein is not, and should not be construed as a recommendation or rating to buy or sell any security. Such stocks are intended for illustrative purposes only. It is possible that at this date or some subsequent date the officers, directors and/or shareholders of Sierra Capital Investors, Inc and its affiliates may own securities or buy or sell securities mentioned herein or those not so mentioned.

CAN SLIM® and variations are marks of Investor’s Business Daily, Inc. and affiliates (‘IBD’). The CAN SLIM® Certified mark is licensed by IBD only to signify successful completion of IBD’s CAN SLIM® Training program. IBD does not license, review or approve of, and is not responsible or liable for any investment advice or other services provided by the user. The user is not an agent of, sponsored by, affiliated with, or owned by IBD and is not authorized by IBD to make any representations, warranties, or promises.

Recent Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice